Investing
Walgreens forecasts annual profit below estimates as COVID vaccine demand shrinks
© Reuters. FILE PHOTO: Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo
(Reuters) – Walgreens Boots Alliance (NASDAQ:) on Thursday forecast a lower-than-estimated profit for financial year 2024 due to a sharp drop in sales of COVID-19 tests, vaccines and treatments.
Walgreens’ lower forecast comes at a time when the company tackles multiple challenges, like persistently weak prescription drug demand, reported walkouts by its pharmacy staff and a shift in focus towards integrated health services.
The second-largest U.S. pharmacy chain operator, whose financial year ends in August, has forecast an annual adjusted profit of $3.20 to $3.50 per share, compared to analysts’ average estimate of $3.72 per share, according to LSEG data.
Read the full article here
-
Personal Finance7 days ago
If you are 60 years old, new 401(k) rules could save you money
-
Investing6 days ago
Bank regulator gives BlackRock new deadline on bank stakes, Bloomberg reports By Reuters
-
Side Hustles5 days ago
LA Rental Prices Skyrocketing Despite Price Gouging Laws
-
Side Hustles5 days ago
How to Craft Marketing Campaigns That Reach Multiple Generations
-
Side Hustles3 days ago
What to Do If TikTok is Banned — How to Protect Your Brand
-
Side Hustles7 days ago
FileJump Offers 2TB of Cloud Storage for $70—With No Strings Attached
-
Make Money7 days ago
10 Easy Ways to Earn Cash Right Now
-
Side Hustles6 days ago
Former Zillow Execs Target $1.3T Market